Results 251 to 260 of about 400,986 (351)

Itraconazole-associated adverse events in fungal infections: a study of a large real-world sample based on the FAERS database (2019-2024). [PDF]

Eur J Clin Pharmacol
Xia T, Chen X, Song X, Mei X.
europepmc   +1 more source

The Role of microRNAs and Cell-Free DNAs in Fungal Infections: Systematic Review and Meta-Analysis of the Literature. [PDF]

J Fungi (Basel)
Kalkanci A, Bozdag F, Fidan I, Guzel Tunccan O, Cetintepe SP, Ilhan MN.   +5 more
europepmc   +1 more source

Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives. [PDF]

EMBO Mol Med
DiPalma DT, Lumbreras MK, Shinohara ML.
europepmc   +1 more source

Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases

, 1994
Enrico Pogliani, Enrico Clini
openalex   +2 more sources

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source

Cutaneous Opportunistic Mycobacterial and Fungal Infections in Adult-Onset Immunodeficiency Due to Anti-Interferon-Gamma Autoantibodies-Decoding Skin Involvement Patterns. [PDF]

Open Forum Infect Dis
Rujiwetpongstorn R, Pinyo P, Prinyaroj N, Chaiwarith R, Kiratikanon S, Tovanabutra N, Chiewchanvit S, Choonhakarn C, Chaowattanapanit S, Chuamanochan M, Meesing A.   +10 more
europepmc   +1 more source

A DESCRIPTIVE STUDY OF FUNGAL INFECTIONS IN CHRONICALLY DISCHARGING EARS

, 2015
S. Sujatha, P G Venugopalan
openalex   +1 more source

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin, Ming‐Lun Yeh, Po‐Cheng Liang, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang   +8 more
wiley   +1 more source